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Target Organ Toxicity: Liver and Kidney
byG. L PIaa* and J. B. Hookt
In the organization of this program, it was
rapidly realized that one could not go in depth in-
to the more sophisticated aspects of liver injury
induced by chemicals. However, it was felt that
certain aspects of the problems involved in this
type of injury should be brought to light so that
an overall grasp of the situation could be at-
tained. Dr. Zimmerman pointed out that "liver in-
jury" is not a single entity, but rather a variety of
abnormal tissue responses and that their detec-
tion is intimately related to the particular altera-
tion concerned. Dr. Smuckler emphasized that al-
terations in hepatic ultrastructure can be numer-
ous and that these can lead to the eventual de-
mise of the hepatocyte. It is not always clear
which alteration is the limiting event. Dr.
Mitchell pointed out that it is now clear that bio-
transformations occur in the liver which lead to
the production of highly toxic metabolites, but
that endogenous protective mechanisms can alter
the potential toxicity of these metabolites. The
relative balance between these two events seems
to be the key to certain types of hepatic injury.
Dr. Plaa re-emphasized the importance of the
quantitative aspects of liver injury. Finally, Dr.
Gray described how in the assessment ofliver in-
jury in the safety evaluation process one needs to
consider both morphologic and biochemical pa-
rameters. These can be converted to data which
lead to quantitative estimates of hepatotoxic
potential.
At the onset of this symposium concerning the
kidney as a target organ of toxicity we were con-
cerned with the state of the art. That is, where
are we today in the study of nephrotoxicity? Fol-
lowing the ingestion of a nephrotoxic drug or
chemical what do we see clinically? What are the
signs and symptoms of nephrotoxicity? How do
we quantify these changes induced by the
* Departement de Phamacologie, Faculte de Medecine,
Universite de Montreal, Montreal, Quebec, Canada.
t Department of Pharmacology-Life Sciences, Michigan
State University, East Lansing, Michigan 48824.
nephrotoxin? What caused the abnormality? Was
the toxin the drug itself or was it a metabolite?
Assuming a nephrotoxic insult has occurred,
what can we do about it? Is this an irreversible
phenomenon or can it be treated? More impor-
tantly, what does the nephrotoxic insult mean to
the individual? Is the change merely one that can
be described histologically or are there profound
effects concerning salt and water metabolism or
the endocrine function of the kidney? In the first
paper of this symposium Dr. Berndt described
currently used techniques for measuring renal
function. That is, how do we know renal function
has been altered and how do we quantify it? He
discussed what these individual measurements
mean in terms of organ function and in terms of
systemic toxicity. Dr. Hirsch provided a com-
prehensive review of in vitro techniques for
quantitatively estimating drug damage to the
kidney. Dr. Oken described experiments relative
to the etiology of renal damage. He concentrated
on questions concerning tubular vs. vascular site
ofaction ofnephrotoxins. Next, Dr. Mazze shared
with us the story ofmethoxyflurane nephrotoxici-
ty. This problem in kidney toxicity was first seen
in man. Dr. Mazze and his colleagues then con-
ducted extensive investigations to determine an
appropriate animal model in which to elucidate
the biochemical mechanisms of this effect. The
last speaker, Dr. Gibson, described the rapidly
developing field of pediatric nephropathy and
presented data demonstrating that drugs admin-
istered prenatally can have profound effects on
renal function measured postnatally.
During the course of this symposium it became
apparent that many members of the audience
were very interested in the in vitro techniques
used to measure renal function. Consequently,
after the symposium Dr. W.O. Berndt was asked
to write a paper describing the use, in detail, of
the slice technique so that the specific meth-
odology might be available to all those interested
in studies on renaltoxicology.
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